Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture
- PMID: 12884094
- DOI: 10.1007/s00595-003-2569-4
Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture
Abstract
Purpose: The combination effects of 5-fluorouracil (5-FU) and cisplatin (CDDP) are herein reported using a drug sensitivity assay, with a special focus on the induction of apoptosis.
Methods: The combination effects of 5-FU and CDDP were examined using in vitro chemosensitivity testing by means of the collagen gel droplet embedded culture drug sensitivity test (CD-DST) in MKN45 and GSS cell lines, and primary gastrointestinal cancer cells ob-tained from 40 patients. Apoptosis was assayed using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin neck end labeling (TUNEL) method.
Results: The combination of 5-FU with CDDP increased the efficacy of 5-FU 1.16-1.35-fold with the GSS cell line and 1.10-2.01-fold with primary gastric and colorectal cancers when the exposure time was 7 days. In primary tumor cells a synergistic action was noted in 15 of 40 (38%) gastric and colorectal cancers. Both 5-FU and CDDP were found to induce apoptosis in GSS and MKN45 cells, and the number of apoptotic cells increased synergistically after the combined treatment in the GSS cases and showed a correlation with the results of CD-DST.
Conclusions: Our findings suggested that the efficacy of the combined treatment with 5-FU and CDDP can be predicted by the in vitro chemosensitivity test and that a synergistic effect might be associated with the induction of apoptosis.
Similar articles
-
Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.Int J Oncol. 2004 Apr;24(4):807-13. Int J Oncol. 2004. PMID: 15010816
-
Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.Int J Oncol. 2002 Mar;20(3):549-55. Int J Oncol. 2002. PMID: 11836567
-
The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.Oncol Rep. 2005 Sep;14(3):609-15. Oncol Rep. 2005. PMID: 16077963
-
[Problems and prospects for combined chemotherapy with 5-fluorouracil and low-dose cisplatin].Gan To Kagaku Ryoho. 1999 Oct;26(11):1575-80. Gan To Kagaku Ryoho. 1999. PMID: 10553415 Review. Japanese.
-
[Cell culture (collagen gel matrix) and its application for chemosensitivity test].Gan To Kagaku Ryoho. 1992 May;19(5):743-8. Gan To Kagaku Ryoho. 1992. PMID: 1580652 Review. Japanese.
Cited by
-
A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma.BMC Cancer. 2006 May 6;6:121. doi: 10.1186/1471-2407-6-121. BMC Cancer. 2006. PMID: 16677397 Free PMC article. Clinical Trial.
-
Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively.Gastric Cancer. 2010 Nov;13(4):231-7. doi: 10.1007/s10120-010-0564-1. Epub 2010 Dec 3. Gastric Cancer. 2010. PMID: 21128058
-
Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer.Mol Clin Oncol. 2013 Jul;1(4):763-767. doi: 10.3892/mco.2013.102. Epub 2013 Apr 11. Mol Clin Oncol. 2013. PMID: 24649243 Free PMC article.
-
Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.World J Gastroenterol. 2006 Sep 21;12(35):5635-43. doi: 10.3748/wjg.v12.i35.5635. World J Gastroenterol. 2006. PMID: 17007015 Free PMC article.
-
Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreas.J Gastroenterol. 2007 Nov;42(11):918-22. doi: 10.1007/s00535-007-2105-1. Epub 2007 Nov 22. J Gastroenterol. 2007. PMID: 18008037
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous